| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 8 May 2025 | 2 May 2025 |
| Asarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2025 ,inter alia, to consider and approve Pursuant to aforementioned regulation, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Thursday, 8th May 2025, inter-alia, to consider and approve the audited financial results for the year ending 31st March 2025 We wish to inform you that the Board of Directors of Asarfi Hospital Limited (the Company), at its meeting held today i.e. on 08TH May, 2025 has considered and approved the audited Standalone and Consolidated Financial Results of the Company for the Standalone & Consolidated quarter ended & year ended 31st March, 2025. (As Per BSE Announcement Dated on :08.05.2025) | ||
| Board Meeting | 28 Mar 2025 | 28 Mar 2025 |
| Disclosure under Reg. 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015 related to CSR Policy for CSR Expenditure was discussed and approved. | ||
| Board Meeting | 31 Jan 2025 | 23 Jan 2025 |
| Asarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 inter alia to consider and approve Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday 31st January 2025 inter-alia to consider and approve the unaudited financial results for the quarter ending 31st December 2024. We wish you to inform you that the Board of Directors of Asarfi Hospital Limited at its meeting held today on 31st January,2025 has consider and aprproved the unaudited Standalone and consolidated Financial Result of the company for the quarter ended 31st December ,2024. (As Per BSE Announcement Dated on: 31/01/2025) | ||
| Board Meeting | 30 Oct 2024 | 22 Oct 2024 |
| Asarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2024 inter alia to consider and approve We hereby given that a meeting of the Board of Directors of the Company will be held on Wednesday 3 We herewith submiting the outcome of Board Meeting along with Unaudited Stanaloan and Consolidated financial result for the half year ended on 30.09.2024. (As per BSE Announcement Dated on 30/10/2024) | ||
| Board Meeting | 7 Oct 2024 | 7 Oct 2024 |
| This is to inform the loan appilication dated 20.08.2024 has been approved by the State Bank of India through sanction letter No-AGM/SME-DHN/2024-25/373 (A) dated 26.09.2024 of Rs.5.28 Crore, the same is placed before the board and the board has discussed and approoved the various terms for grant of the loan. | ||
| Board Meeting | 20 Aug 2024 | 13 Aug 2024 |
| Asarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/08/2024 inter alia to consider and approve A meeting of the Board of Directors of the Company will be held on Tuesday 20th August 2024 at 03:00 p.m. at the registered office of the Company. Outcome Of Board Meeting under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) 2015. (As Per BSE Announcement dated on 20.08.2024) | ||
| Board Meeting | 19 Jun 2024 | 19 Jun 2024 |
| Outcome of Board Meeting for starting of Asarfi Cancer Institute unit and apply for subsidy for Asarfi cancer Institute Unit. | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
